title: The effects of combined therapy of rheumatoid arthritis on the acute phase reactants.
abstract: The paper presents the results of studies of acute phase reactants in the 60 treated patients with rheumatoid arthritis. Patients were divided into two groups, depending on the applied treatment: group I (n = 30) was treated with methotrexate, sulfasalazine and hydroxychloroquine, and group II (n = 30) with methotrexate. The results of our study shows that there is a statistically significant reduction in the value of acute phase reactants and clinical parameters after treatment in both investigated groups of patients, and also a significant statistical difference between the first and second group of treated patients.
authors.affiliation: Faculty of Medicine, University of Pristina, Rr. "Bulevardi i dëshmorëve" p.n., 10000 Pristina, Kosovo.
authors.forename: Sylejman
authors.initials: S
authors.lastname: Rexhepi
authors.forename: Mjellma
authors.initials: M
authors.lastname: Rexhepi
authors.forename: Vjollca
authors.initials: V
authors.lastname: Sahatçiu-Meka
authors.forename: Ejup
authors.initials: E
authors.lastname: Pllana
authors.forename: Gani
authors.initials: G
authors.lastname: Dragusha
authors.forename: Masar
authors.initials: M
authors.lastname: Gashi
authors.forename: Blerta
authors.initials: B
authors.lastname: Rexhepi
mesh_terms: D000209:Acute-Phase Proteins / Q000032:analysis*; D000328:Adult; D000368:Aged; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000097:blood / Q000188:drug therapy*; D001799:Blood Sedimentation; D002097:C-Reactive Protein / Q000032:analysis; D004359:Drug Therapy, Combination; D005260:Female; D005340:Fibrinogen / Q000032:analysis; D006801:Humans; D008297:Male; D008875:Middle Aged; D055815:Young Adult
chemical_list: D000209:Acute-Phase Proteins; D018501:Antirheumatic Agents; D005340:Fibrinogen; D002097:C-Reactive Protein